Expertise
Our Leadership team has extensive collective experience in steering products from pre-clinical to commercial manufacture.
Science-led
Our approach is scientific, collaborative and open, ensuring an open dialogue and transparency that fits your project.
Award-winning
We are a leading CDMO recognised for numerous awards including a King's Award For Enterprise.
Nimble
We adapt to your project needs, and pledge to never relegating it to the bottom of the list.
Who we are
We're a flexible and nimble CDMO.
As a leading Contract, Development, and Manufacturing Organisation, our defining traits lie in our adaptability and nimbleness, enabling rapid product introduction within 4-6 weeks.
Through a science-led approach we align to your drug development needs
from pre-clinical to late phase and commercial manufacture.
Our flexibility ensures that we can problem-solve, meet your timescales and deliver solutions that meet patient targets.
What makes us different
Science-led approach driving unparalleled project delivery.
At Upperton, your molecule reigns supreme. We pledge an unwavering commitment to prioritising your project, never relegating it to the bottom of a list.
Our expansive project team covers every layer of our operations, ensuring a thorough and dedicated approach tailored to your needs.
With extensive experience, our Leadership Team excels in steering products from pre-clinical to late-stage manufacture.
Your molecule isn’t merely a part of a process; it becomes our primary focus, receiving unparalleled attention and expertise to ensure its success.
Our Mission.
Passionate about science, we strive to build strong customer relationships and exceed their expectations.
We develop and manufacture high-quality drug products and share in our customers dedication to change the lives of patients.
How we can help you
Pharmaceutical CDMO services.
As a CDMO like no other, our flexibility ensures that we can meet your demands and expectations.
Our capabilities and pharmaceutical CDMO services include:
- Formulation development
- Phase 1 to Phase 3 clinical supply
- Process scale-up and optimisation
- Registration activities
- Analytical development and validation
Watch our videos to learn more.
